בוקולאם 2.5 מ"ג

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Aktiv ingrediens:

MIDAZOLAM AS HYDROCHLORIDE 2.5 MG

Tilgjengelig fra:

NEOPHARM CURE (2005) LTD

ATC-kode:

N05CD08

Legemiddelform:

OROMUCOSAL SOLUTION

Administreringsrute:

BUCCAL

Produsert av:

SCM PHARMA LIMITED, UK

Terapeutisk gruppe:

MIDAZOLAM

Indikasjoner:

Treatment of prolonged, acute, convulsive seizures in infants, toddlers, children and adolescents (from 3 months to < 18 years). Buccolam must only be used by parents/carers where the patient has been diagnosed to have epilepsy. For infants between 3-6 months of age treatment should be in a hospital setting where monitoring is possible and resuscitation equipment is available.

Autorisasjon dato:

2013-05-01